Advertisement

The Liver-Impaired Patient

  • Nancy Withers

Among all organs in the human body, the liver is the largest and carries out the greatest number of functions. The liver’s important and multiple activities have impact on all body systems, including the nervous system. The relationship between the liver and the brain has been known for centuries (Frerichs, 1860; Lewis and Howdle, 2003; Tarter et al., 1989;Wilson, 1912). Patients with hepatic dysfunction frequently experience neuropsychiatric syndromes, of which the most well known is hepatic encephalopathy (Ferenci et al., 2002).

Keywords

Liver Disease Chronic Hepatitis Hepatic Encephalopathy Sustained Virologic Response Alcoholic Liver Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bonkovsky H, Mehta S. Hepatitis C: a review and update. J Am Acad Dermatol 2001;44:159–182.PubMedCrossRefGoogle Scholar
  2. Center for Disease Control, National Center for Health Statistics, HEA, US. Leading causes of death and numbers of deaths, according to age. United States 1980 and 2003. Hyattsville, MD: CDC, 2005:182–183; available at http://www.cdc.gov/nchs/data/hus/hus05.pdf.
  3. Collie A. Cognition in liver disease. Liver Int 2005;25:1–8.PubMedCrossRefGoogle Scholar
  4. Crone C, Gabriel GM. Comprehensive review of hepatitis C for psychiatrists: risks, screening, diagnosis, treatment and interferon-based complications. J Psychiatr Pract 2003;9:93–110.PubMedCrossRefGoogle Scholar
  5. Crone CC, Gabriel GM, Di Martini A. An overview of psychiatric issues in liver disease for the consultation-liaison psychiatrist. Psychosomatics 2006;47:188–205.PubMedCrossRefGoogle Scholar
  6. Desmond CP, Roberts SK, Dudley F, et al. Sustained virologic response rates and durability of the response to interferon-based therapies in hepatitis C patients treated in the clinical setting. J Viral Hepatitis 2006;13:311–315.CrossRefGoogle Scholar
  7. Doi F, Kakizaki S, Takagi H, et al. Long term outcome of interferon-(alpha)-induced autoimmune thyroid disorders in chronic hepatitis C. Liver Int 2005;25:242–246.PubMedCrossRefGoogle Scholar
  8. Farrell GC. Nonalcoholic steatohepatitis: What is it, and why is it important in the Asia-Pacific region? J Gastroenterol Hepatol 2003;18:124–138.PubMedCrossRefGoogle Scholar
  9. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy—definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congress of Gastroenterology, Vienna. 1998. Hepatology 2002;35:715–721.CrossRefGoogle Scholar
  10. Fontana RJ, Bieliauskas A, Back-Madruga C, et al. (2005) Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial. J Hepatol 2005;43:614–622.PubMedCrossRefGoogle Scholar
  11. Forton DM, Allsop JM, Cox IJ, et al. (2005) A review of cognitive impairment and cerebral metabolity abnormalities in patients with hepatitis C infection. AIDS 2005;19(suppl):S53–S63.PubMedCrossRefGoogle Scholar
  12. Forton DM, Thomas HC, Murphy CA, et al. Hepatitis C and cognitive impairments in a cohort of patients with mild liver disease. Hepatology, 2002;35:433–439.PubMedCrossRefGoogle Scholar
  13. Frerichs FT. A Clinical Treatise on Diseases of the Liver by Dr. Friedrich Theodor Frerichs (trans. Charles Murchison). London: New Sydenham Society, 1860:193–246.Google Scholar
  14. Hensley DA, Withers NW. Addiction psychiatric assessment of veterans with chronic hepatitis C. J Psychosom Res 2003;55:121.Google Scholar
  15. Hensley DA, Withers NW, Spira J. Aggression, depression, anxiety and quality of life in veterans with chronic hepatitis C. J Psychosom 2003;55:121–122.Google Scholar
  16. Hilsabeck RC. Neurocognitive changes in chronic liver disease. J Psychosom Res 2003;55: 121.CrossRefGoogle Scholar
  17. Hilsabeck RC, Malek-Ahmadi PI. Neurobehavioral correlates of chronic hepatitis C. J Psychopathol Behav Assess 2004;26:203–210.CrossRefGoogle Scholar
  18. Hilsabeck R, Perry W, Hassanein TI. Neuropsychological impairments in patients with chronic hepatitis C. Hepatology 2002;35:440–446.PubMedCrossRefGoogle Scholar
  19. Hilsabeck RC, Withers NW, Wetter S. Neuropsychiatric changes after liver transplantation. J Psychosom Res 2003;55:116.CrossRefGoogle Scholar
  20. Klos KJ, Ashkog JE, Josephs KA, Fealey RD, Cowl CR, Kumar N. Neurologic spectrum of chronic liver failure and basal ganglia T1 hyperintensity on magnetic resonance imaging: probably manganese toxicity. Arch Neurol 2005;62:1385–1390.PubMedCrossRefGoogle Scholar
  21. Kramer L, Bauer E, Gendo A, et al. Neurophysiological evidence of cognitive impairment in patients without hepatic encephalopathy after transjugular intrahepatic portosystemic shunts. Am J Gastroenterol 2002;97:162–166.PubMedCrossRefGoogle Scholar
  22. Kramer L, Hofer H, Bauer E, et al. (2005). Relative impact of fatigue and subclinical cognitive brain dysfunction I health-related quality of life in chronic hepatitis C infection. AIDS, 19(suppl):S85–S92.PubMedCrossRefGoogle Scholar
  23. Kraus MR, Schafer A, Faller H, Csef H, Scheurlen M. Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy. J Clin Psychiatry 2003;64:708–714.PubMedCrossRefGoogle Scholar
  24. Kraus MR, Shafer A, Wissman S, Reimer P, Scheurlen M. Neurocognitive changes in patients with hepatitis C receiving interferon alfa-2b and ribavirin. Clin Pharmacol Ther 2005;77:90–100.PubMedCrossRefGoogle Scholar
  25. Lewis M, Howdle PD. The Neurology of Liver Failure. Q J Med 2003;96:623–633.Google Scholar
  26. Lieber CS. Pathogenesis and treatment of alcoholic liver disease: progress in the last 50 years. Roczniki Akademii Medycznej Biaymstoku 2005;50:7–20.Google Scholar
  27. McCullough AJ. (2002). Update on nonalcoholic liver disease. J Clin Gastroenterol 2002;34: 255–262.PubMedCrossRefGoogle Scholar
  28. McDonnell SM, Preston BL, Jewell SA, et al. (1999). A survey of 2, 851 patients with hemochromatosis: symptoms and response to treatment. Am J Med 1999;106:619–624.PubMedCrossRefGoogle Scholar
  29. O’Carroll RE, Couston M, Cossar J, Masterton G, Hayes PC. Psychological outcome and quality of life following liver transplantation: a prospective, national, single-center study. Liver Transplantation 2003;9:712–720.PubMedCrossRefGoogle Scholar
  30. Pantiaga C, Rodrigo LR, Cuesta M, Lopez L, Arias JL (2003). Cognitive deficits in patients with hepatic cirrhosis and in liver transplant recipients. Journal of Neuropsychology & Clinical Neuroscience, 15:84–89.Google Scholar
  31. Raison CL, Demetrashvili M, Capuron L, Miller A. Neuropsychiatric adverse events of interferon-(alpha): recognition and treatment. CNS Drugs 2005;19:105–123.PubMedCrossRefGoogle Scholar
  32. Rambaldi A, Jacobs BP, Iaquinto G, Gluud C. Milk thistle for alcoholic and/or hepatitis B or C liver disease. A systematic Cochrane hepatobiliary group review with meta analysis of randomized clinical trials. Am J Gastroenterol, 2005;100:2583–2591.PubMedCrossRefGoogle Scholar
  33. Reichenberg A, Gorman J, Dieterich D. Interferon-induced depression and cognitive impairment in hepatitis C patients: a 72 weeks prospective study. AIDS 2005;19(suppl):S174–S178.PubMedCrossRefGoogle Scholar
  34. Reimer J, Backmund, Hassan C (2005). New psychiatric and psychological aspects of diagnosis and treatment of hepatitis C and relevance for opiate dependence. Current Opinion in Psychiatry, 18:678–683.PubMedCrossRefGoogle Scholar
  35. Reuben A. Alcohol and the liver. Curr Opin Gastroenterol 2006;22:263–271.PubMedGoogle Scholar
  36. Sorrell JH, Zolnikov BJ, Sharma A, Jinnai I. Cognitive impairment in people diagnosed with end-stage liver disease evaluated for liver transplantation. Psychiatry Clin Neurosci 2006;60:174–181.PubMedCrossRefGoogle Scholar
  37. Tarter RE, Edwards KL, Van Thiel D. Neuropsychological dysfunction due to liver disease. In: Tarter RE, Van Thiel DH, Edwards KL, eds. Medical Neuropsychology. New York: Plenum Press, 1989:95–97.Google Scholar
  38. Walton NW, Bowden SC. Does liver dysfunction explain neuropsychological status in recently detoxified alcoholic-dependent clients? Alcohol 1997;32:287–295.Google Scholar
  39. Wessely S, Pariante C. Fatigue, depression and chronic hepatitis C infection. Psychol Med 2002;32:1–10.PubMedCrossRefGoogle Scholar
  40. Wilson SAK. Progressive lenticular degeneration. A familial nervous disease associated with cirrhosis of the liver. Brain 1912;34:295–307.CrossRefGoogle Scholar
  41. Withers NW. Aggression induced by interferon alfa-2b during long-term therapy for chronic hepatitis C. J Neuropsychiatry Clin Neurosci 2003;15:259.Google Scholar
  42. Withers NW. Deceptions in addiction psychiatry. Am J Forensic Psychiatry 2001;22:7–26.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Nancy Withers
    • 1
  1. 1.University of HawaiiHonoluluUSA

Personalised recommendations